Epstein Barr Virus (EBV) testing: PCR versus serology

Jaybee00

Senior Member (Voting Rights)
Trying to understand which is the more important EBV detection method: via serology or via PCR.

In my case I tested very positive for both EBV VCA IGG and IGM.
But my PCR test was negative.

What is the correct way to interpret this? Seems like a lot of physicians dont really understand how to interpret these results either.
 
Is PCR the gold standard and if so, why do you need to do the serology tests? Asking since in MECFS there is evidence that a subset of patients have persistently high levels of IgG and IgM EBV antibodies hanging around.
 
My understanding is:

If PCR is done reliably it will pick up active virus replication during infection or reactivation in someone who is immunocompromised. But it may miss recent viral replication if there is no virus in blood.

Serological tests were done historically before PCR existed. The rule was that you interpreted two samples, usually two weeks apart. It was the change in the levels that was useful, much more than a single measure. If there was active infection you might see IgM rise or IgG rise a bit later.

For a time there was a suggestion that a single IgM level being raised was an indicator of recent or active infection, and more so for particular antigens (I think VCA). But it was then shown that single values do not reliably show recent infection. IgM levels may persist over time. (Worth remembering that between individuals viral antibody titres vary hugely so it is hard to define a useful normal range. It makes much more sense to use yourself as a control and look at changes over time.)

My reading of the situation is that for any one individual the presence of IgM and IgG antibodies to EBV VCA really only shows that there has been past infection. Some physicians (generally not virologists) have tried to use serology to diagnose active infection or reactivation and no doubt labs will be happy to sell testing on that basis. But I don't think it means much.

My understanding also is that when EBV antibodies have been looked at in ME/CFS populations and controls not much difference shows up if at all. There will be people with 'high' levels in any sample.
 
My understanding also is that when EBV antibodies have been looked at in ME/CFS populations and controls not much difference shows up if at all. There will be people with 'high' levels in any sample.
I think much the same is true for HHV6 in blood but then Jackie Cliff found increased levels of HHV6B in saliva and is now looking deeper into that with an NIH grant. I wish I could remember the update she presented....... I guess we are always learning.
 
No just the VCA—as I mentioned above there does seem to be confusion around these tests.
Some clinics such as Montoya at Stanford used to use antibody tests as justification for prescribing antivirals. Their first clinical trial was then used as justification. But their own follow up and much larger blinded study showed absolutely no benefit in ME/CFS as a group. When Montoya left, that practice stopped.

Disclaimer - there are some individuals with ME/CFS who have active EBV replication and some of those people report benefit from anti-virals.
 
Back
Top Bottom